ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04658	Th1 and Th2 cell differentiation	3/6	96/7206	4.45225195224e-05
ko04064	NF-kappa B signaling pathway	3/6	96/7206	4.45225195224e-05
ko04659	Th17 cell differentiation	3/6	106/7206	5.9926195553e-05
ko04380	Osteoclast differentiation	3/6	134/7206	0.000120719996699
ko05160	Hepatitis C	3/6	153/7206	0.000179122427073
ko04621	NOD-like receptor signaling pathway	3/6	157/7206	0.000193394323124
ko05161	Hepatitis B	3/6	173/7206	0.000257902483853
ko04217	Necroptosis	3/6	178/7206	0.000280609089178
ko05168	Herpes simplex infection	3/6	182/7206	0.000299686228537
ko05167	Kaposi's sarcoma-associated herpesvirus infection	3/6	191/7206	0.000345661911894
ko05169	Epstein-Barr virus infection	3/6	206/7206	0.000432098212172
ko04622	RIG-I-like receptor signaling pathway	2/6	62/7206	0.00106861357555
ko05212	Pancreatic cancer	2/6	83/7206	0.00190809886565
ko04657	IL-17 signaling pathway	2/6	87/7206	0.00209450022276
ko04662	B cell receptor signaling pathway	2/6	88/7206	0.00214241230116
ko05222	Small cell lung cancer	2/6	89/7206	0.00219084785916
ko04920	Adipocytokine signaling pathway	2/6	89/7206	0.00219084785916
ko04668	TNF signaling pathway	2/6	120/7206	0.00394869822506
ko04660	T cell receptor signaling pathway	2/6	124/7206	0.00421119105411
ko05145	Toxoplasmosis	2/6	126/7206	0.00434545099759
ko04630	Jak-STAT signaling pathway	2/6	132/7206	0.00476022800765
ko05200	Pathways in cancer	3/6	492/7206	0.00541411680265
ko04071	Sphingolipid signaling pathway	2/6	162/7206	0.00710002033386
ko05164	Influenza A	2/6	167/7206	0.00753237300262
ko04210	Apoptosis	2/6	180/7206	0.00871208226819
ko04932	Non-alcoholic fatty liver disease (NAFLD)	2/6	182/7206	0.0089006457067
ko05152	Tuberculosis	2/6	187/7206	0.00938023546445
ko05203	Viral carcinogenesis	2/6	277/7206	0.0199336295778
ko05166	HTLV-I infection	2/6	292/7206	0.0220304097941
ko01523	Antifolate resistance	1/6	30/7206	0.024729130984
ko04010	MAPK signaling pathway	2/6	321/7206	0.0263425454951
ko04623	Cytosolic DNA-sensing pathway	1/6	41/7206	0.0336678118474
ko04151	PI3K-Akt signaling pathway	2/6	390/7206	0.0379052053679
ko04624	Toll and Imd signaling pathway	1/6	49/7206	0.0401256996671
ko04930	Type II diabetes mellitus	1/6	54/7206	0.0441435857678
ko05321	Inflammatory bowel disease (IBD)	1/6	56/7206	0.0457468110124